Myocardial expression of baculoviral p35 alleviates doxorubicin-induced cardiomyopathy in rats

Human Gene Therapy

Volumn 14, Issue 10, 2003, Pages 947-957

  Date, Taro ^a   Luo, Zhengyu ^a   Yamakawa, Midori ^a   Belanger, Adam J ^a   Scaria, Abraham ^a   Cheng, Seng H ^a   Gregory, Richard J ^a   Mochizuki, Seibu ^b   Jiang, Canwen ^a  

^a GENZYME CORPORATION   (United States)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; CASPASE 3; CASPASE 8; CYTOCHROME C; DOXORUBICIN; PROTEIN P35; REACTIVE OXYGEN METABOLITE; VIRUS PROTEIN;

ADENOVIRUS 2; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BACULOVIRUS; CARDIOTOXICITY; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME RELEASE; GENE TRANSFER; HEART LEFT VENTRICLE PERFORMANCE; HEART LEFT VENTRICLE WALL; HEART MUSCLE CELL; HISTOPATHOLOGY; MALE; NEWBORN; NONHUMAN; PROTEIN EXPRESSION; RAT; TRANSGENE;

ADENOVIRIDAE; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARDIOMYOPATHIES; CASPASES; CELLS, CULTURED; CHROMOSOMES, ARTIFICIAL, BACTERIAL; DOXORUBICIN; GENE THERAPY; GENETIC VECTORS; INHIBITOR OF APOPTOSIS PROTEINS; MALE; MYOCARDIUM; RATS; RATS, INBRED LEW; RATS, WISTAR; TUMOR CELLS, CULTURED; VIRAL PROTEINS;

ADENOVIRIDAE; ANIMALIA; HUMAN ADENOVIRUS TYPE 2; UNIDENTIFIED BACULOVIRUS;

EID: 0038235766     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303403766682214     Document Type: Article

References (37)

1. ANDRIEU-ABADIE, N., JAFFREZOU, J.P., HATEM, S., LAURENT, G., LEVADE, T., and MERCAIDER, J.J. (1999). L-Carnitine prevents doxorubicin-induced apoptosis of cardiac myocytes: Role of inhibition of ceramide generation. FASEB J. 13, 1501-I510.
2. ARAKI, T., SHIBATA, M., TAKANO, R., HISAHARA, S., IMAMURA, S., FUKUUCHI, Y., SARUTA, T., OKANO, H., and MIURA, M. (2000). Conditional expression of anti-apoptotic protein p35 by Cre-mediated DNA recombination in cardiomyocytes from loxP-p35-transgenic mice. Cell Death Differ. 7, 485-492.
3. BELANGER, A.J., SCARIA, A., LU, H., SULLIVAN, J.A., CHENG, S.H., GREGORY, R.J., and JIANG, C. (2001). Fas ligand/Fas-mediated apoptosis in human coronary artery smooth muscle cells: Therapeutic implications of fratricidal mode of action. Cardiovasc. Res. 51, 749-761.
4. BELANGER, A.J., LU, H., DATE, T., LIU, L.X., VINCENT, K.A., AKITA, G.Y., CHENG, S.H., GREGORY, R.J., and JIANG, C. (2002). Hypoxia up-regulates expression of peroxisome proliferator-activated receptor angiopoietin-related gene (PGAR) in cardiomyocytes: Role of hypoxia inducible factor 1α. J. Mol. Cell. Cardiol. 34, 765-774.
5. BUMP, N.J., HACKETT, M., HUGUNIN, M., SESHAGIRI, S., BRADY, K., CHEN, P., FERENZ, C., FRANKLIN, S., GHAYUR, T., and LI, P. (1995). Inhibition of ICE family proteases by baculovirus antiapoptotic protein p35. Science 269, 1885-1888.
6. CLEM, R.J., FECHHERMER, M., and MILLER, L.K. (1991). Prevention of apoptosis by a baculovirus gene during infection of insect cells. Science 254, 1388-1330.
7. DATE, T., BELANGER, A.J., LIU, L., SCARIA, A., CHENG, S.H., MOCHIZUKI, S., GREGORY, R.J., and JIANG, C. (2002). Adenovirus-mediated expression of p35 prevents hypoxia/reoxygenation injury by reducing reactive oxygen species and caspase activity. Cardiovasc. Res. 55, 309-319.
8. DELL'ACQUA, G., POLISHCHUCK, R., FALLON, J.T., and GORDON, J.W. (1999). Cardiac resistance to Adriamycin in transgenic mice expressing a rat α-cardiac myosin heavy chain/human multiple drug resistance 1 fusion gene. Hum. Gene Ther. 10, 1269-1279.
9. GARDIN, J.M., SIRI, F.M., KITSIS, R.N. EDWARDS, J.G., and LEINWAND, L.A. (1995). Echocardiographic assessment of left ventricular mass and systolic function in mice. Circ. Res. 76, 907-914.
10. GOTZ, C., and MONTENARH, M. (1996). p53: DNA damage, DNA repair, and apoptosis. Rev. Physiol. Biochem. Pharmacol. 127, 65-95.
11. HARE, J,M. (2001). Oxidative stress and apoptosis in heart failure progression. Circ. Res. 89, 198-200.
12. JIANG, C., O'CONNOR, S.P., ARMENTANO, D., BERTHELETTE, P.B., SCHIAVI, S.C., JEFFERSON, D.M., SMITH, A.E., WADSWORTH, S.C., and CHENG, S.H. (1996). Ability of adenovirus vectors containing different CFTR transcriptional cassettes to correct ion transport defects in CF cells. Am. J. Physiol. 271, L527-L537.
13. KANG, Y.J., CHEN, Y., and EPSTEIN, P.N. (1996). Suppression of doxorubicin cardiotoxicity by overexpression of catalase in the heart of transgenic mice. J. Biol. Chem. 271, 12610-12616.
14. KANG, Y.J., CHEN, Y., YU, A., VOSS-MCCOWAN, M., and EPSTEIN, P.N. (1997). Overexpression of metallothionein in the heart of transgenic mice suppresses doxorubicin cardiotoxicity. J. Clin. Invest. 100, 1501-1506.
15. KOTAMRAJU, S., KONOREV, E.A., JOSEPH, J., and KALYANARAMAN, B. (2000). Doxorubicin-induced apoptosis in endothelial cells and cardiomyocytes is ameliorated by nitrone spin traps and ebselen: Role of reactive oxygen and nitrogen species. J. Biol. Chem. 275, 33585-33592.
16. L reduces doxorubicin-induced myocardial damage but fails to control cardiac gene downregulation. Cardiovasc. Res. 53, 936-943.
17. LAUGWITZ, K.L., MORETTI, A., WEIG, H.J., GILLITZER, A., PINKERNELL, K., OTT, T., PRAGST, I., STADELE, C., SEYFARTH, M., SCHOMIG, A., and UNGERER, M. (2001). Blocking caspase-activated apoptosis improves contractility in failing myocardium. Hum. Gene Ther. 12, 2051-2063.
18. 1-Adrenergic stimulation of cardiac gene transcription in neonatal rat myocardial cells: Effects on myosin light chain-2 gene expression. J. Biol. Chem. 263, 7352-7358.
19. LEEUWENBURGH, C., HANSEN, P.A., HOLLOSZY, J.O., and HEINECKE, J.W. (1999). Hydroxyl radical generation during exercise increases mitochondrial protein oxidation and levels of urinary dityrosine. Free Radic. Biol. Med. 27, 186-192.
20. LI, T., and SINGAL, P.K. (2000). Adriamycin-induced early changes in myocardial antioxidant enzymes and their modulation by probucol. Circulation 102, 2105-2110.
21. NAGATA, S. (1999). Fas ligand-induced apoptosis. Annu. Rev. Genet. 33, 29-55.
22. NAKAMURA, T., UEDA, Y., JUAN, Y., KATSUDA, S., TAKAHASHI, H., and KOH, E. (2000). Fas-mediated apoptosis in Adriamycin-induced cardiomyopathy in rats: In vivo study. Circulation 102, 572-578.
23. L/caspase-3 interaction. Circulation 103, 555-561.
24. SAH, N.K., TANEJA, T.K., PATHAK, N., BEGUM, R., ATHAR, M., and HASNAIN, S.E. (1999). The baculovirus antiapoptotic p35 gene also functions via an oxidant-dependent pathway. Proc. Natl. Acad. Sci. U.S.A. 96, 4838-4843.
25. SAWYER, D.B., FUKAZAWA, R., ARSTALL, M.A., and KELLY, R.A. (1999). Daunorubicin-induced apoptosis in rat cardiac myocytes is inhibited by dexrazoxane. Circ. Res. 84, 257-265.
26. SAWYER, D.B., ZUPPINGER, C., MILLER, T.A., EPPENBERGER, H.M., and SUTER, T.M. (2002). Modulation of anthracycline-induced myofibrillar disarray in rat ventricular myocytes by neuregulin-1β and anti-erbB2: Potential mechanism for trastuzumab-induced cardiotoxicity. Circulation 105, 1551-1554.
27. SCAFFIDI, C., FULDA, S., SRINIVASAN, A., FRIESEN, C., LI, F., TOMASELLI, K.J., DEBATIN, K.M., KRAMMER, P.H., and PETER, M.E. (1998). Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17, 1675-1687.
28. SINGAL, P.K., LI, T., KUMAR, D., DANELISEN, I., and ILISKOVIC, N. (2000). Adriamycin-induced heart failure: Mechanism and modulation. Mol. Cell. Biochem. 207, 77-85.
29. SIVESKI-ILISKOVIC, N., HILL, M., CHOW, D.A., and SINGAL, P.K. (1995). Probucol protects against Adriamycin cardiomyopathy without interfering with its antitumor effect. Circulation 91, 10-15.
30. WANG, G.W., KLEIN, J.B., and KANG, Y.J. (2001). Metallothionein inhibits doxorubicin-induced mitochondrial cytochrome c release and caspase-3 activation in cardiomyocytes. J. Pharmacol. Exp. Ther. 298, 461-468.
31. WANG, L., MA, W., MARKOVICH, R., CHEN, J.W., and WANG, P.H. (1998). Regulation of cardiomyocyte apoptotic signaling by insulin-like growth factor I. Circ. Res. 83, 516-522.
32. WANG, X. (2001). The expanding role of mitochondria in apoptosis. Genes Dev. 15, 2922-2933.
33. WEISS, R.B. (1992). The anthracyclines: Will we ever find a better doxorubicin? Semin. Oncol. 19, 670-686.
34. XUE, D., and HORVITZ, H.R. (1995). Inhibition of the Caenorhabditis elegans cell-death protease CED-3 by a CED-3 cleavage site in baculovirus p35 protein. Nature 377, 248-251.
35. YOUNG, R.C., OZOLS, R.F., and MYERS, C.E. (1981). The anthracycline antineoplastic drugs. N. Engl. J. Med. 305, 139-153.
36. ZHOU, Q., and KREBS, J.F. (1998). Interaction of the baculovirus antiapoptotic protein p35 with caspases: Specificity, kinetics, and characterization of the caspase/p35 complex. Biochemistry 37, 10757-10765.
37. ZHOU, S., STARKOV, A., FROBERG, M.K., LEINO, R.L., and WALLACE, K.B. (2001). Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin. Cancer Res. 61, 771-777.